Videos and Recordings - Neurology

Videos and Recordings - Neurology

February 14, 2020
Learn more about how Disarm Therapeutics and the Quanterix Accelerator Lab are powering biomarker testing for axonal degeneration. For more information: https://go.quanterix.com/simoaservices
October 08, 2019
Our CEO Kevin Hrusovsky joined Lyanne Alfaro on set of Nasdaq's
June 24, 2019
Delivering ultrasensitive biomarker measurement you can count on.
June 24, 2019
Ultra-Sensitive Biomarker Measurement in Neurology Research using Simoa Technology. Utilization of Blood Biomarkers in Neurodegenerative Disease Research Biomarker World Congress and IO Pharma Congress, World Pharma Week, June 2019
Bloomberg Radio Interview | February 07, 2019
In a conversation with Tom Moroney and Peter Barnes that highlights the power of the protein, Quanterix CEO Kevin Hrusovsky explains how Simoa is powering advances in research, specifically for the detection and treatment of Alzheimer’s and other neurodegenerative diseases.  

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more